Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Tricia Elliott MD, FAAFP
Tricia C. Elliott MD, FAAFP Associate Editor
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
See All Experts
Published in Primary Care

Journal Scan / Research · April 08, 2023

Effect of the FDA Mandate Limiting Acetaminophen Dose in Prescription Combination Opioid Products on the Rates of Hospitalizations and Acute Liver Failure

JAMA: The Journal of the American Medical Association

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Timothy Overton MD, MPH

JAMA: The Journal of the American Medical Association
Association of FDA Mandate Limiting Acetaminophen (Paracetamol) in Prescription Combination Opioid Products and Subsequent Hospitalizations and Acute Liver Failure
JAMA 2023 Mar 07;329(9)735-744, BJ Orandi, MC McLeod, PA MacLennan, WM Lee, RJ Fontana, CJ Karvellas, BM McGuire, CE Lewis, NM Terrault, JE Locke

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated